CHINA SXT PHARMACEUTICALS IN (SXTC)

VGG2161P1403 - Common Stock

0.4789  -0.05 (-9.64%)

After market: 0.488 +0.01 (+1.9%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024
Revenue
YoY % growth
2.6M
-45.61%		1.97M
-24.23%		1.929M
-2.11%
EBITDA
YoY % growth
-4.87M
-163.24%		-5.01M
-2.87%		-1.889M
62.29%
EBIT
YoY % growth
-5.19M
-135.91%		-5.26M
-1.35%		-2.092M
60.22%
Operating Margin
-199.62%-267.01%-108.49%
EPS
YoY % growth
N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2022
Q2Q % growth
Q2 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q2 2020
Q2Q % growth
Q4 2019
Q2Q % growth
Q2 2019
Q2Q % growth
Q4 2018
Q2Q % growth
Q3 2018
Q2Q % growth
Q2 2018
Q2Q % growth
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2024
Q2Q % growth		 988.91K
30.12%		%
Q2 2024
Q2Q % growth		 939.58K
-22.35%		%
Q4 2023
Q2Q % growth		 760K
-51.59%		%
Q2 2023
Q2Q % growth		 1.21M
17.48%		%
Q4 2022
Q2Q % growth
Q2 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q2 2020
Q2Q % growth
Q4 2019
Q2Q % growth
Q2 2019
Q2Q % growth
Q4 2018
Q2Q % growth
Q3 2018
Q2Q % growth
Q2 2018
Q2Q % growth
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A